Research Article
Antimicrobial and Antiproliferative Potential of
Anadenanthera colubrina (Vell.) Brenan
Rennaly de Freitas Lima,
1
Érika Ponchet Alves,
1
Pedro Luiz Rosalen,
2
Ana Lúcia Tasca Gois Ruiz,
3
Marta Cristina Teixeira Duarte,
3
Vivian Fernandes Furletti Góes,
3
Ana Cláudia Dantas de Medeiros,
1
Jozinete Vieira Pereira,
1
Gustavo Pina Godoy,
1
and Edja Maria Melo de Brito Costa
1
1
Department of Dentistry, Para´ ıba State University (UEPB), 58429-500 Campina Grande, PB, Brazil
2
Department of Pharmacology and Anesthesiology, Piracicaba School of Dentistry, University of Campinas (UNICAMP),
13414-903 Piracicaba, SP, Brazil
3
Center for Chemical, Biological and Agricultural Research, University of Campinas (UNICAMP), P.O. Box 6171,
13083-970 Campinas, SP, Brazil
Correspondence should be addressed to Edja Maria Melo de Brito Costa; edjacosta@gmail.com
Received 24 March 2014; Revised 1 June 2014; Accepted 11 June 2014; Published 30 June 2014
Academic Editor: Wagner Vilegas
Copyright © 2014 Rennaly de Freitas Lima et al. Tis is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Te aim of the present study was to perform an in vitro analysis of the antimicrobial and antiproliferative potential of an extract from
Anadenanthera colubrina (Vell.) Brenan (angico) and chemically characterize the crude extract. Antimicrobial action was evaluated
based on the minimum inhibitory concentration (MIC), minimum bactericidal/fungicidal concentration, and the inhibition of
formation to oral bioflm. Cell morphology was determined through scanning electron microscopy (SEM). Six strains of tumor
cells were used for the determination of antiproliferative potential. Te extract demonstrated strong antifungal activity against
Candida albicans ATCC 18804 (MIC = 0.031 mg/mL), with similar activity found regarding the ethyl acetate fraction. Te extract
and active fraction also demonstrated the capacity to inhibit the formation of Candida albicans to oral bioflm afer 48 hours, with
median values equal to or greater than the control group, but the diference did not achieve statistical signifcance ( > 0.05). SEM
revealed alterations in the cell morphology of the yeast. Regarding antiproliferative activity, the extract demonstrated cytostatic
potential in all strains tested. Te present fndings suggest strong antifungal potential for Anadenanthera colubrina (Vell.) Brenan
as well as a tendency toward diminishing the growth of human tumor cells.
1. Introduction
Te high prevalence rates of adverse oral conditions and
the limitations of available treatment methods have led to
increasing interest among the scientifc community in alter-
native therapies [1]. Tis interest has fueled research into
natural compounds with adequate efectiveness and fewer
adverse efects in the control of oral bioflm, which is
responsible for the development of conditions such as tooth
decay and candidiasis [2].
Bacterial and fungal infections pose a challenge to
researchers and clinicians, especially in immunocompro-
mised patients. Tis situation is further complicated by the
development of resistance to conventional medications on the
part of a large number of microorganisms. Terefore, studies
are needed for the discovery of safe, stable drugs from sources
found in nature that are efective against resistant bacteria and
fungi [3]. Such drugs could also beneft a greater number of
individuals due to the low cost and greater availability [4].
Medicinal plants have become an important source for
the discovery of novel antimicrobial agents. Raw extracts
from plants and isolated substances in these extracts have
demonstrated activity against a number of pathogens [5]. It is
also important to determine the potential of natural products
with biological activity regarding possible harm to normal
cells as well as damage to tumor cells to establish possible
therapeutic uses [6].
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 802696, 7 pages
http://dx.doi.org/10.1155/2014/802696